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There was no statistically significant difference between the two groups. A single determination of the plasma carcinoembryonic antigen level has no prognostic value in patients with bronchial carcinoma.
Carcinoembryonic antigen (CEA) was first described by Freedman in 1965 (Gold and Freedman, 1965a; Gold and Freedman, 1965b; Gold and Freedman, 1965c) . Originally it was thought to be an antigen specific for colonic carcinoma. Subsequently this antigen has been discovered in other gastrointestinal tumours, breast tumours, and bronchial carcinomas.
It appears also to be present at a very low level in normal tissue. The development of a radioimmunoassay method by Thomson and co-workers (Thomson et al., 1969) and the subsequent modifications of this method made it possible to detect CEA in plasma (Chu, Reynoso, and Hansen, 1972) . Normal persons rarely exceed a plasma level of 2 5 ng/ml, as measured by the method of Hansen (Hansen, Lance, and Krupey, 1971; Hansen et al., 1974) . Raised levels of CEA have been detected in various malignant diseases (Gerfo, Krupey, and Hansen, 1971; Chu and Reynoso, 1972; Laurence et al., 1972; Reynoso et al., 1972; Concannon, Dalbow, and Frich, 1973; Hansen et al., 1974; Terry et al., 1974) but also in nonmalignant inflammatory conditions and in healthy smokers Stevens and Mackay, 1973; Terry et al., 1974) .
Our study was started in order to determine the clinical value of plasma CEA levels in bronchial carcinoma and to see if we could in this way discriminate between patients with bronchial carcinoma and patients with other pulmonary disorders. Since most of the patients with bronchial carcinoma also had clinical evidence of chronic bronchitis it was logical to compare them to a group of patients with chronic bronchitis. Furthermore, we decided to determine the CEA level in patients with chronic bronchitis during an acute infectious exacerbation since inflammation seems to be an important stimulus for CEA liberation in the blood or CEA production by tissue.
We also tried to correlate the initial CEA level to survival rate in patients with bronchial carcinoma.
MATERIAL AND METHODS
CEA levels were determined in the plasma of 49 patients with histologically proven bronchial carcinoma and in 25 patients with an acute infective exacerbation of chronic bronchitis. Follow-up studies were carried out as far as possible. The CEA level was determined by the zirconium gel radio immunoassay method of Hansen et al. (1971) , and this was done at the medical research department of Hoffman La Roche, Basel.
Statistical analysis was performed using the Wilcoxon test and calculation of linear correlation.
RESULTS
The CEA plasma levels in the two groups are shown in Figure 1 .
Accepting 2 5 ng/ml as the upper limit of normal (Hansen et al., 1974) Follow-up of patients with bronchial carcinoma was continued over a period of one year; during this time 70% of these patients died. When comparing the initial CEA level of patients who died during this year with the level in patients who survived, no statistically significant difference could be found and patients who proved to be operable did not have different CEA levels from the other carcinoma patients (Fig. 3) . Moreover, there was no significant correlation between the initial CEA level and the survival time in patients who died (Fig. 4) . values were found among the carcinoma patients.
When the patients with chronic bronchitis were tested again one to two weeks after the first determination, after the acute exacerbation had responded to treatment with antibiotics, sympathomimetics, methylxanthines, and corticosteroids, no significant lowering of the CEA level was observed (Fig. 2) (Hansen et al., 1974) . Other studies reported similar findings (Vincent and Chu, 1973; Terry et al., 1974) . CEA has also been found in bronchial carcinoma tissue and even in normal lung tissue at a very low concentration (Pusztaszeri and Mach, 1973; Sizaret and Martin, 1973 
